These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Transcobalamin-binding capacities in vitamin B12-related diseases. MacDonald C, Bessent R, Adams J. Am J Clin Pathol; 1981 May; 75(5):677-83. PubMed ID: 7234754 [Abstract] [Full Text] [Related]
8. Serum vitamin B 12 and folic acid levels in patients with fasciolopsiasis. Areekul S, Jaroonvesama N, Charoenlarp K, Kasemsuth R, Cheeramakara C. Southeast Asian J Trop Med Public Health; 1979 Mar; 10(1):67-72. PubMed ID: 483018 [Abstract] [Full Text] [Related]
12. Abnormalities of serum transcobalamins in sickle cell disease (HbSS) in Black Africa. Osifo BO, Adeyokunnu A, Parmentier Y, Gerard P, Nicolas JP. Scand J Haematol; 1983 Feb; 30(2):135-40. PubMed ID: 6300991 [Abstract] [Full Text] [Related]
13. The clinical significance of serum transcobalamins in myeloid leukemia and other myeloproliferative disorders. Rachmilewitz B, Rachmilewitz M. Isr J Med Sci; 1977 Jul; 13(7):710-5. PubMed ID: 270474 [No Abstract] [Full Text] [Related]
16. Studies on derivation of transcobalamin 3 from granulocytes. Enhancement by lithium and elimination by fluoride of in vitro increments in vitamin B12-binding capacity. Scott JM, Bloomfield FJ, Stebbins R, Herbert V. J Clin Invest; 1974 Jan; 53(1):228-39. PubMed ID: 4202670 [Abstract] [Full Text] [Related]
20. Prognostic significance of changes in serum transcobalamin levels in cancer patients with chemotherapy-induced granulocytopenia. Sulkes A, Rachmilewitz B, Rachmilewitz M, Fuks Z. Oncology; 1983 Mar; 40(3):218-22. PubMed ID: 6843947 [Abstract] [Full Text] [Related] Page: [Next] [New Search]